PLX PHARMA INC.
Live / Registered — Registered (as of 14 Dec 2021)
What this means for you
Registered since 14 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90188918
- Registration number
- 6591723
- Mark type
- Design + words
- Filed
- 17 Sept 2020
- Published for opposition
- 16 Feb 2021
- Registered
- 14 Dec 2021
- Attorney of record
- Mary L. Grieco
Goods and services
- Class 005 — Pharmaceuticals: Aspirin; Pain relief medication; Fever relief medication; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of arthritis, rheumatoid arthritis, and osteoarthritis; Cardiovascular pharmaceuticals; Pharmaceutical treatments for the prevention and treatment of vascular disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating hypertension; Pharmaceutical products for treating diabetes; Pharmaceuticals in the field of human medicine
Owner
- PLX ACQUISITION COMPANY, LLC, BUFFALO, NY, US
- PLX PHARMA INC., Sparta, NJ, US
- PLX PHARMA INC., Sparta, NJ, US
- PLX PHARMA INC., Sparta, NJ, US
Prior registrations
Prosecution history
- 20 Sept 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Oct 2021 — USE AMENDMENT FILED
- 22 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 13 Apr 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Feb 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Feb 2021 — PUBLISHED FOR OPPOSITION
- 27 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jan 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jan 2021 — EXAMINER'S AMENDMENT ENTERED
- 11 Jan 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED